Advanced search
Publication Cover
International Review of Psychiatry Volume 17, 2005 - Issue 3: Psychotropic Drug Epidemiology and Everyday Clinical Practice
Submit an article Journal homepage
21
Views
3
CrossRef citations to date
0
Altmetric
Research Article

New generation psychotropics and the automatism of prescribing

Corrado Barbui Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, University of Verona, Verona, Italy
&
Michele Tansella Department of Medicine and Public Health, Section of Psychiatry and Clinical Psychology, University of Verona, Verona, Italy
Pages 139-141 | Published online: 19 Aug 2009

References

  • Anderson, I. M. (2001). Meta-analytical studies on new anti-depressants. British Medical Journal, 57, 161–178.
  • Barbui, C., Ciuna, A., Nosé, M., Levi, D., Patten, S., Amaddeo, F., et al. (2004). The changing pattern of inpatient antipsychotic drug use in Italy. Journal of Clinical Psychopharmacology, 24, 559–561.
  • Chisholm, D., Sanderson, K., Ayuso-Mateos, J.L., & Saxena, S. (2004). Reducing the global burden of depression. British Journal of Psychiatry, 184, 393–403.
  • Correll, C. U., Leucht, S., & Kane, J. M. (2004). Lower risk for tardive dyskinesia associated with second-generation antipsy-chotics: A systematic review of 1-year studies. American Journal of Psychiatry, 161, 414–425.
  • Crawford, M. J. (2004). Depression: International intervention for a global problem. British Journal of Psychiatry, 184, 379–380.
  • Leucht, S., Wahlbeck, K., Hamann, J., & Kissling, W. (2003). New generation antipsychotics versus low-potency conventional antipsychotics: A systematic review and meta-analysis. Lancet, 361, 1581–1589.
  • Moynihan, R., Heath, I., & Henry, D. (2002). Selling sickness: The pharmaceutical industry and disease mongering. British Medical Journal, 324, 886–891.
  • Murray, C.J.L., & Lopez, A. (1996). Global Health Statistics: A com-pendium of incidence, prevalence and mortality estimates for over 2000 conditions. Cambridge Harvad School of Public Health.
  • Pariante, C., & Tansella, M. (2005). Controversies in antidepres-sant therapy. Editorial. Epidemiologia e Psichiatria Sociale, in press.
  • Rose, N. (2003). Neurochemical selves. Society November/ December 2003,46–59.
  • Spigset, 0., & Martensson, B. (1999). Drug treatment of depression. British Medical Journal, 318, 1188–1191.
  • Starcevic, V. (2002). Opportunistic 'rediscovery' of mental disorders by the pharmaceutical industry. Psychotherapy & Psychosomatics, 71, 305–310.
  • Ustun, T. B., Ayuso-Mateos, J.L., Chatterji, S., Mathers, C., & Murray, C.J.L. (2004) Global burden of depressive disorders in the year 2000. British Journal of Psychiatry, 184, 386–392.
  • Wang, P. S., Berglund, P., & Kessler, R. C. (2000). Recent care of common mental disorders in the United States. Journal of General Internal Medicine, 15, 284–292.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.